(Q35124712)

6 August 2017

1 reference

title

Atypical antipsychotics in the treatment of bipolar disorder (English)

1 reference

6 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

1 January 2024

4

Paul E Keck

1 reference

6 August 2017

author name string

Stephen M. Strakowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12739998

1 January 2024

Melissa P. Del Bello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12739998

1 January 2024

Caleb M. Adler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12739998

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14656566.4.5.751

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

Expert Opinion on Pharmacotherapy

1 January 2024

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

751-760

1 reference

Comparative efficacy and tolerability of drug treatments for bipolar disorder

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Olanzapine versus divalproex in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

A novel augmentation strategy for treating resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

A review of the effect of atypical antipsychotics on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Fixed-dosed risperidone in mania: an open experimental trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Quetiapine: a review of its safety in the management of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Ziprasidone: a new atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.5.751

Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

Novel antipsychotics and new onset diabetes

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

Risperidone treatment of bipolar disorder.

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

1 January 2024

30

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

1 January 2024

32

1 reference

https://api.crossref.org/works/10.1517/14656566.4.5.751

1 January 2024

Identifiers

1 reference

6 August 2017

1 reference